Today’s Top Buy: Curaleaf

Here’s why Curaleaf Holdings (TSXV:CURA) remains my top cannabis pick for investors to consider right now.

| More on:
Cannabis stocks have fallen.
You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn more

A new “green rush” is upon us. Or, at least, cannabis investors hope so.

The key driver of this rush to cannabis stocks remains legalization. This time, anticipation of U.S. legalization has set the stage for another bout of hysteria of late.

Indeed, I believe that much of the hype right now in the cannabis space is unwarranted. That said, there are a few key companies I’d target for those looking to take advantage of the growth potential in this nascent industry.

Here’s why Curaleaf Holdings (TSXV:CURA) is my top pick for such investors today.

State-specific legalization driving speculation of federal legalization in U.S.

Late last month, New York governor Andrew Cuomo signed the S.854A/A.1248A bill that legalizes licensing of dispensaries across the state. Following this move, NY is set to become the country’s second-largest legal cannabis market. Legislative leaders will focus on setting up the state’s Cannabis Control Board and Office of Cannabis Management, which will regulate licensing, home cultivation, etc.

That’s big news in its own right.

However, cannabis investors are taking this news and running with it.

The hope many investors have is that these state-specific moves to legalize cannabis will ultimately force Biden’s hand. Biden has actually been relatively cold on the idea of legalizing cannabis, as per his previous commentary on the subject. Accordingly, cannabis investors appear to be latching onto any ray of hope President Biden could warm up to the idea.

New York is about as blue a state as they come, so there could be some political pressure that’s building on this front. However, with a pandemic still out of control south of the border, bigger priorities are taking over right now, as they should.

That’s not to discount the potential (or likelihood) of cannabis becoming federally legal in the United States. I’m just uncertain of the timing at this point.

Legalization potential varies among cannabis producers

If and when cannabis becomes legal, investors should want to own the top dogs in this space.

That means companies that actually have a footprint in the U.S.

Most Canadian cannabis producers are precluded from selling THC products in the U.S. by law (various banking regulations and U.S. listing regulations make it so). Accordingly, investing in some of the biggest Canadian cannabis names isn’t likely to be a winning bet right now, in my view.

The entry fee to get into the U.S. market following legalization is rising. To acquire one’s way into the U.S. will be ultra-expensive. Doing so organically will take time. In either case, investors in Canadian cannabis companies are likely to lose out to huge U.S. cannabis producers like Curaleaf with a dominant vertically integrated business model from coast to coast in the U.S.

Indeed, Curaleaf’s business model is among the most attractive of its peers. Additionally, the company’s valuation is much cheaper than many Canadian cannabis companies right now.

In my view, it’s the winner for those looking to play this space right now.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Chris MacDonald has no position in any of the stocks mentioned.

More on Cannabis Stocks

Retirement plan
Dividend Stocks

4 Stocks That Could Turn $100,000 Into $500,000 by the Time You Retire

Companies such as Brookfield Asset Management have the potential to consistently beat the broader markets and deliver stellar returns to…

Read more »

IMAGE OF A NOTEBOOK WITH TFSA WRITTEN ON IT
Cannabis Stocks

TFSA Investors: 2 U.S. Stocks I’m Never Selling

Canadians looking to diversify their portfolios and gain exposure to U.S. stocks can purchase shares of high-growth companies such as…

Read more »

A cannabis plant grows.
Cannabis Stocks

Aurora Cannabis (TSX:ACB) Keeps Burning Cash as Revenue Falls

Aurora Cannabis (TSX:ACB)(NASDAQ:ACB) is still losing money. Its revenue is declining, too.

Read more »

Cannabis stocks have fallen.
Cannabis Stocks

Why Canopy Growth Stock Climbed as Much as 20% on Monday

A glimmer of hope from the U.S. Congress may lead to renewed interest in marijuana investing.

Read more »

TSX Today
Cannabis Stocks

TSX Today: What to Watch for in Stocks on Friday, July 15

A continued selloff in metals prices is likely to pressure the commodity-heavy TSX Composite benchmark at the open today.

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

With the Cannabis Industry Trading Ultra-Cheap, Organigram Stock Looks Like a Screaming Buy!

After selling off for years, Organigram stock now offers tonnes of value and is easily one of the best cannabis…

Read more »

edit Cannabis leaves of a plant on a dark background
Cannabis Stocks

Canopy Growth Stock: The Only Cannabis Stock to Consider Long Term

The cannabis stock industry remains an incredibly high risk one, but Canopy Growth (TSX:WEED)(NYSE:CGC) stock provides the best opportunity for…

Read more »

edit Cannabis leaves of a plant on a dark background
Cannabis Stocks

Should You Stay Away From HEXO Stock?

HEXO (TSX:HEXO)(NASDAQ:HEXO) stock is on a downward spiral, and there is little hope it is going to recover soon.

Read more »